WallStSmart

Nutex Health Inc (NUTX)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 2039% more annual revenue ($18.11B vs $846.72M). NUTX leads profitability with a 21.2% profit margin vs 8.4%. UHS trades at a lower P/E of 7.0x. UHS earns a higher WallStSmart Score of 72/100 (B).

NUTX

Buy

63

out of 100

Grade: C+

Growth: 7.3Profit: 9.5Value: 8.3Quality: 7.5
Piotroski: 4/9Altman Z: 2.49

UHS

Strong Buy

72

out of 100

Grade: B

Growth: 6.0Profit: 7.0Value: 6.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NUTXUndervalued (+61.7%)

Margin of Safety

+61.7%

Fair Value

$269.07

Current Price

$200.24

$68.83 discount

UndervaluedFair: $269.07Overvalued
UHSSignificantly Overvalued (-24.0%)

Margin of Safety

-24.0%

Fair Value

$186.49

Current Price

$174.83

$11.66 premium

UndervaluedFair: $186.49Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NUTX5 strengths · Avg: 9.6/10
P/E RatioValuation
7.5x10/10

Attractively priced relative to earnings

Operating MarginProfitability
57.8%10/10

Strong operational efficiency at 57.8%

EPS GrowthGrowth
95.9%10/10

Earnings expanding 95.9% YoY

Return on EquityProfitability
27.8%9/10

Every $100 of equity generates 28 in profit

Profit MarginProfitability
21.2%9/10

Keeps 21 of every $100 in revenue as profit

UHS3 strengths · Avg: 9.7/10
P/E RatioValuation
7.0x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Return on EquityProfitability
20.2%9/10

Every $100 of equity generates 20 in profit

Areas to Watch

NUTX2 concerns · Avg: 2.5/10
Market CapQuality
$1.32B3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-13.6%2/10

Revenue declined 13.6%

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : NUTX

The strongest argument for NUTX centers on P/E Ratio, Operating Margin, EPS Growth. Profitability is solid with margins at 21.2% and operating margin at 57.8%.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Price/Book, Return on Equity. PEG of 1.14 suggests the stock is reasonably priced for its growth.

Bear Case : NUTX

The primary concerns for NUTX are Market Cap, Revenue Growth.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

NUTX profiles as a declining stock while UHS is a value play — different risk/reward profiles.

NUTX carries more volatility with a beta of 2.02 — expect wider price swings.

UHS is growing revenue faster at 8.3% — sustainability is the question.

UHS generates stronger free cash flow (216M), providing more financial flexibility.

Bottom Line

UHS scores higher overall (72/100 vs 63/100). NUTX offers better value entry with a 61.7% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nutex Health Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?